XTL Biopharmaceuticals Ltd SEC filings XTLB

XTL Biopharmaceuticals Ltd has 546 filings in SEC EDGAR's recent list, going back to Nov 17, 2004. Its latest annual report, Form 20-F, was filed on Jun 30, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 14, 2026.

XTL Biopharmaceuticals Ltd SEC filings
Form Description Filed Period
6-K Current report (foreign issuer) Oct 14, 2026 Oct 14, 2026
6-K Current report (foreign issuer) Aug 5, 2026 Aug 5, 2026
6-K Current report (foreign issuer) Jul 21, 2026 Jul 21, 2026
20-F Annual report (foreign issuer) Jun 30, 2026 Dec 31, 2025
6-K Current report (foreign issuer) Jun 30, 2026 Jun 30, 2026
6-K Current report (foreign issuer) Jun 29, 2026 Jun 29, 2026
6-K Current report (foreign issuer) Jun 23, 2026 Jun 22, 2026
6-K Current report (foreign issuer) May 22, 2026 May 22, 2026
6-K Current report (foreign issuer) May 15, 2026 May 15, 2026
6-K Current report (foreign issuer) May 7, 2026 May 7, 2026
NT 20-F Notification of late filing Apr 30, 2026 Dec 31, 2025
6-K Current report (foreign issuer) Apr 29, 2026 Apr 29, 2026
6-K Current report (foreign issuer) Mar 20, 2026 Mar 20, 2026
6-K Current report (foreign issuer) Mar 10, 2026 Mar 10, 2026
6-K Current report (foreign issuer) Feb 27, 2026 Feb 27, 2026
6-K Current report (foreign issuer) Feb 24, 2026 Feb 24, 2026
6-K Current report (foreign issuer) Feb 23, 2026 Feb 23, 2026
6-K Current report (foreign issuer) Feb 17, 2026 Feb 17, 2026
6-K Current report (foreign issuer) Jan 28, 2026 Jan 28, 2026
6-K Current report (foreign issuer) Jan 23, 2026 Jan 23, 2026
6-K Current report (foreign issuer) Jan 23, 2026 Jan 23, 2026
6-K Current report (foreign issuer) Jan 13, 2026 Jan 13, 2026
6-K Current report (foreign issuer) Jan 13, 2026 Jan 13, 2026
6-K Current report (foreign issuer) Dec 30, 2025 Dec 30, 2025
6-K Current report (foreign issuer) Dec 29, 2025 Dec 29, 2025
6-K Current report (foreign issuer) Dec 12, 2025 Dec 12, 2025
6-K Current report (foreign issuer) Dec 5, 2025 Dec 5, 2025
6-K Current report (foreign issuer) Oct 23, 2025 Oct 22, 2025
6-K Current report (foreign issuer) Jul 28, 2025 Jul 28, 2025
6-K Current report (foreign issuer) Jul 21, 2025 Jul 21, 2025
6-K/A Amendment no. 1 to form 6-k Jun 18, 2025 Jun 18, 2025
6-K Current report (foreign issuer) Jun 13, 2025 Jun 13, 2025
20-F Annual report (foreign issuer) Apr 30, 2025 Dec 31, 2024
6-K Current report (foreign issuer) Apr 7, 2025 Apr 7, 2025
6-K Current report (foreign issuer) Mar 4, 2025 Mar 4, 2025
6-K Current report (foreign issuer) Feb 3, 2025 Feb 3, 2025
6-K Current report (foreign issuer) Dec 30, 2024 Dec 30, 2024
6-K Current report (foreign issuer) Dec 30, 2024 Dec 30, 2024
6-K Current report (foreign issuer) Nov 19, 2024 Nov 19, 2024
6-K Current report (foreign issuer) Nov 12, 2024 Nov 12, 2024
6-K Current report (foreign issuer) Oct 15, 2024 Oct 15, 2024
6-K Current report (foreign issuer) Aug 14, 2024 Aug 14, 2024
6-K Current report (foreign issuer) Jul 22, 2024 Jul 22, 2024
6-K Current report (foreign issuer) Jun 12, 2024 Jun 11, 2024
6-K Current report (foreign issuer) Jun 5, 2024 Jun 5, 2024
6-K Current report (foreign issuer) May 13, 2024 May 13, 2024
6-K Current report (foreign issuer) Apr 30, 2024 Apr 30, 2024
20-F Annual report (foreign issuer) Apr 30, 2024 Dec 31, 2023
6-K Current report (foreign issuer) Apr 2, 2024 Apr 2, 2024
6-K/A Amendment no. 1 to form 6-k Mar 21, 2024 Mar 21, 2024
6-K Current report (foreign issuer) Mar 21, 2024 Mar 21, 2024
6-K Current report (foreign issuer) Mar 20, 2024 Mar 20, 2024
6-K Current report (foreign issuer) Nov 15, 2023 Nov 15, 2023
6-K Current report (foreign issuer) Oct 20, 2023 Oct 20, 2023
6-K Current report (foreign issuer) Aug 10, 2023 Aug 10, 2023
6-K Current report (foreign issuer) May 16, 2023 May 16, 2023
20-F Annual report (foreign issuer) Mar 22, 2023 Dec 31, 2022
6-K Current report (foreign issuer) Mar 2, 2023 Mar 2, 2023
6-K Current report (foreign issuer) Feb 23, 2023 Feb 23, 2023
6-K/A Amendment 1 to form 6-k Feb 1, 2023 Feb 1, 2023
6-K Current report (foreign issuer) Jan 20, 2023 Jan 20, 2023
6-K Current report (foreign issuer) Nov 29, 2022 Nov 29, 2022
6-K Current report (foreign issuer) Aug 24, 2022 Jun 30, 2022
6-K Current report (foreign issuer) Jun 1, 2022 Jun 1, 2022
20-F Annual report (foreign issuer) Mar 30, 2022 Dec 31, 2021
6-K Current report (foreign issuer) Jan 26, 2022 Jan 26, 2022
6-K Current report (foreign issuer) Jan 19, 2022 Jan 19, 2022
6-K Current report (foreign issuer) Dec 16, 2021 Dec 16, 2021
6-K Current report (foreign issuer) Nov 24, 2021 Nov 24, 2021
6-K Current report (foreign issuer) Aug 24, 2021 Jun 30, 2021
424B3 Prospectus Jun 9, 2021 —
EFFECT Filing Jun 7, 2021 —
POS AM Post-effective amendment no. 1 to form f-1 Jun 2, 2021 —
6-K Current report (foreign issuer) May 19, 2021 May 19, 2021
20-F/A Amended annual report (foreign issuer) May 19, 2021 Dec 31, 2020
6-K Current report (foreign issuer) May 19, 2021 May 19, 2021
6-K Current report (foreign issuer) Apr 5, 2021 Apr 5, 2021
6-K Current report (foreign issuer) Mar 29, 2021 Mar 29, 2021
20-F Annual report (foreign issuer) Mar 15, 2021 Dec 31, 2020
6-K Current report (foreign issuer) Feb 22, 2021 Feb 22, 2021
6-K Current report (foreign issuer) Jan 7, 2021 Jan 7, 2021
6-K Current report (foreign issuer) Dec 31, 2020 Dec 31, 2020
6-K Current report (foreign issuer) Nov 25, 2020 Nov 25, 2020
6-K Current report (foreign issuer) Nov 12, 2020 Nov 12, 2020
6-K Current report (foreign issuer) Aug 24, 2020 Aug 24, 2020
6-K Current report (foreign issuer) Jul 7, 2020 Jul 7, 2020
6-K Current report (foreign issuer) Jun 30, 2020 Jun 30, 2020
6-K Current report (foreign issuer) May 27, 2020 May 27, 2020
6-K Current report (foreign issuer) May 26, 2020 May 26, 2020
6-K Current report (foreign issuer) May 26, 2020 May 26, 2020
20-F Annual report (foreign issuer) Mar 12, 2020 Dec 31, 2019
6-K Current report (foreign issuer) Jan 29, 2020 Jan 29, 2020
6-K Current report (foreign issuer) Jan 22, 2020 Jan 22, 2020
6-K/A Amendment no. 1 to form 6-k Jan 13, 2020 Jan 13, 2020
6-K Current report (foreign issuer) Dec 18, 2019 Dec 18, 2019
6-K Current report (foreign issuer) Nov 27, 2019 Nov 27, 2019
6-K Current report (foreign issuer) Oct 31, 2019 Oct 31, 2019
6-K Current report (foreign issuer) Sep 4, 2019 Sep 4, 2019
6-K Current report (foreign issuer) May 30, 2019 May 30, 2019
20-F Annual report (foreign issuer) Mar 11, 2019 Dec 31, 2018
6-K Current report (foreign issuer) Dec 27, 2018 Dec 27, 2018
6-K Current report (foreign issuer) Dec 20, 2018 Dec 20, 2018
6-K Current report (foreign issuer) Nov 15, 2018 Nov 15, 2018
6-K Current report (foreign issuer) Nov 8, 2018 Nov 8, 2018
6-K Current report (foreign issuer) Nov 1, 2018 Nov 1, 2018
6-K Current report (foreign issuer) Jul 24, 2018 Jul 24, 2018
6-K Current report (foreign issuer) May 30, 2018 May 29, 2018
6-K Current report (foreign issuer) May 22, 2018 May 22, 2018
6-K Current report (foreign issuer) May 15, 2018 May 15, 2018
6-K Current report (foreign issuer) Apr 10, 2018 Apr 10, 2018
20-F Annual report (foreign issuer) Mar 15, 2018 Dec 31, 2017
424B3 Prospectus Mar 7, 2018 —
EFFECT Filing Mar 6, 2018 —
CORRESP Letter to the SEC Mar 2, 2018 —
F-1/A Filing Feb 28, 2018 —
F-1/A Filing Feb 1, 2018 —
6-K Current report (foreign issuer) Dec 6, 2017 Dec 6, 2017
6-K Current report (foreign issuer) Nov 27, 2017 Nov 27, 2017
6-K Current report (foreign issuer) Oct 23, 2017 Oct 23, 2017
6-K Current report (foreign issuer) Sep 26, 2017 Sep 26, 2017
6-K Current report (foreign issuer) Sep 12, 2017 Sep 12, 2017
6-K Current report (foreign issuer) Aug 3, 2017 Aug 3, 2017
6-K Current report (foreign issuer) Jul 27, 2017 Jul 27, 2017
6-K Current report (foreign issuer) Jun 22, 2017 Jun 22, 2017
6-K Current report (foreign issuer) Jun 15, 2017 Jun 15, 2017
6-K Current report (foreign issuer) Apr 27, 2017 Apr 27, 2017
6-K Current report (foreign issuer) Apr 5, 2017 Apr 5, 2017
6-K Current report (foreign issuer) Apr 4, 2017 Apr 4, 2017
20-F/A Amended annual report (foreign issuer) Apr 3, 2017 Dec 31, 2016
20-F Annual report (foreign issuer) Mar 30, 2017 Dec 31, 2016
6-K Current report (foreign issuer) Mar 30, 2017 Mar 30, 2017
D Filing Mar 29, 2017 —
6-K Current report (foreign issuer) Mar 22, 2017 Mar 22, 2017
6-K Current report (foreign issuer) Mar 9, 2017 Mar 9, 2017
6-K Current report (foreign issuer) Mar 7, 2017 Mar 7, 2017
D Filing Mar 1, 2017 —
6-K Current report (foreign issuer) Mar 1, 2017 Mar 1, 2017
6-K Current report (foreign issuer) Feb 22, 2017 Feb 21, 2017
424B5 Prospectus supplement Feb 22, 2017 —
6-K Current report (foreign issuer) Feb 17, 2017 Feb 17, 2017
6-K Current report (foreign issuer) Jan 25, 2017 Jan 25, 2017
6-K Current report (foreign issuer) Jan 5, 2017 Jan 5, 2017
6-K Current report (foreign issuer) Jan 5, 2017 Jan 5, 2017
6-K Current report (foreign issuer) Dec 6, 2016 Dec 6, 2016
6-K Current report (foreign issuer) Nov 14, 2016 Nov 14, 2016
F-1/A Filing Nov 8, 2016 —
CORRESP Letter to the SEC Nov 7, 2016 —
6-K Current report (foreign issuer) Sep 27, 2016 Sep 27, 2016
6-K Current report (foreign issuer) Sep 27, 2016 Sep 27, 2016
6-K Current report (foreign issuer) Sep 7, 2016 Sep 7, 2016
6-K Current report (foreign issuer) Aug 11, 2016 Aug 11, 2016
6-K Current report (foreign issuer) Jun 1, 2016 Jun 1, 2016
20-F Annual report (foreign issuer) Mar 31, 2016 Dec 31, 2015
6-K Current report (foreign issuer) Mar 31, 2016 Mar 31, 2016
6-K Current report (foreign issuer) Mar 24, 2016 Mar 24, 2016
6-K Current report (foreign issuer) Mar 21, 2016 Mar 21, 2016
6-K Current report (foreign issuer) Mar 9, 2016 Mar 9, 2016
6-K Current report (foreign issuer) Mar 2, 2016 Mar 2, 2016
6-K Current report (foreign issuer) Feb 22, 2016 Feb 22, 2016
6-K Current report (foreign issuer) Feb 18, 2016 Feb 18, 2016
6-K Current report (foreign issuer) Feb 10, 2016 Feb 10, 2016
6-K Current report (foreign issuer) Jan 27, 2016 Jan 27, 2016
UPLOAD Letter from the SEC Jan 26, 2016 —
6-K Current report (foreign issuer) Jan 25, 2016 Jan 25, 2016
6-K Current report (foreign issuer) Jan 13, 2016 Jan 13, 2016
6-K Current report (foreign issuer) Jan 11, 2016 Jan 11, 2016
F-1 Registration statement (foreign issuer) Dec 31, 2015 —
6-K Current report (foreign issuer) Dec 29, 2015 Dec 29, 2015
6-K Current report (foreign issuer) Dec 1, 2015 Dec 1, 2015
6-K Current report (foreign issuer) Oct 13, 2015 Oct 13, 2015
6-K Current report (foreign issuer) Sep 21, 2015 Sep 21, 2015
6-K Current report (foreign issuer) Sep 10, 2015 Sep 10, 2015
6-K Current report (foreign issuer) Sep 1, 2015 Sep 1, 2015
6-K Current report (foreign issuer) Sep 1, 2015 Sep 1, 2015
6-K Current report (foreign issuer) Aug 26, 2015 Aug 26, 2015
6-K Current report (foreign issuer) Jun 8, 2015 Jun 8, 2015
20-F Annual report (foreign issuer) Apr 28, 2015 Dec 31, 2014
6-K Current report (foreign issuer) Apr 7, 2015 Apr 6, 2015
424B5 Prospectus supplement Apr 1, 2015 —
6-K Current report (foreign issuer) Mar 31, 2015 Mar 31, 2015
6-K Current report (foreign issuer) Mar 25, 2015 Mar 25, 2015
6-K Current report (foreign issuer) Mar 16, 2015 Mar 16, 2015
6-K Current report (foreign issuer) Feb 17, 2015 Feb 17, 2015
6-K Current report (foreign issuer) Dec 30, 2014 Dec 30, 2014
6-K Current report (foreign issuer) Dec 8, 2014 Dec 8, 2014
6-K Current report (foreign issuer) Dec 1, 2014 Dec 1, 2014
6-K Current report (foreign issuer) Dec 1, 2014 Dec 1, 2014
6-K Current report (foreign issuer) Nov 25, 2014 Nov 25, 2014
6-K Current report (foreign issuer) Nov 4, 2014 Nov 4, 2014
6-K Current report (foreign issuer) Nov 3, 2014 Nov 3, 2014
6-K Current report (foreign issuer) Oct 27, 2014 Oct 27, 2014
6-K Current report (foreign issuer) Oct 3, 2014 Oct 3, 2014
FWP Free writing prospectus Sep 26, 2014 —
424B5 Prospectus supplement Sep 26, 2014 —
6-K Current report (foreign issuer) Sep 23, 2014 Sep 23, 2014
6-K Current report (foreign issuer) Sep 2, 2014 Sep 2, 2014
6-K Current report (foreign issuer) Jun 18, 2014 Jun 18, 2014
6-K Current report (foreign issuer) Jun 2, 2014 Jun 2, 2014
6-K Current report (foreign issuer) May 19, 2014 May 19, 2014
EFFECT Filing Apr 4, 2014 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
XTLB (Nasdaq)
Incorporated in
Israel
Headquarters
New York, NY
SEC filer status
Non-accelerated filer
SEC CIK
1023549

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.